$CBUS
Cibus, Inc.

2023 Q1 Form 10-K Financial Statement

#000119312523058346 Filed on March 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $42.00K $42.00K $157.0K
YoY Change 31.25% -97.84% -99.4%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $42.00K $42.00K $157.0K
YoY Change 31.25% -168.85% -106.11%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $2.296M $1.009M $10.97M
YoY Change -27.8% -73.36% -28.86%
% of Gross Profit 5466.67% 2402.38% 6989.81%
Research & Development $2.209M $2.346M $11.55M
YoY Change -24.89% -18.03% 1.92%
% of Gross Profit 5259.52% 5585.71% 7358.6%
Depreciation & Amortization $486.0K $376.0K $1.534M
YoY Change 31.35% -33.1% -34.39%
% of Gross Profit 1157.14% 895.24% 977.07%
Operating Expenses $4.505M $3.355M $22.53M
YoY Change -26.4% -49.54% -15.82%
Operating Profit -$4.463M -$3.313M -$22.37M
YoY Change -26.7% -50.63% -23.74%
Interest Expense $3.000K $476.0K $75.00K
YoY Change -99.36% -237.18% -94.76%
% of Operating Profit
Other Income/Expense, Net -$910.0K $5.566M
YoY Change -286.86% 29194.74%
Pretax Income -$5.394M -$2.837M -$16.89M
YoY Change -4.0% -59.8% -42.15%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.400M -$2.837M -$16.90M
YoY Change -3.9% -59.8% -42.12%
Net Earnings / Revenue -12857.14% -6754.76% -10764.33%
Basic Earnings Per Share -$1.09 -$0.37
Diluted Earnings Per Share -$1.09 -$0.06 -$0.37
COMMON SHARES
Basic Shares Outstanding 49.38M 48.84M 46.00M
Diluted Shares Outstanding 4.941M 46.00M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.054M $3.427M $3.427M
YoY Change -88.12% -75.21% -75.21%
Cash & Equivalents $2.054M $3.427M $3.427M
Short-Term Investments
Other Short-Term Assets $529.0K $705.0K $705.0K
YoY Change -68.66% -48.09% -48.09%
Inventory
Prepaid Expenses $154.0K $210.0K
Receivables $0.00
Other Receivables
Total Short-Term Assets $2.583M $4.132M $4.132M
YoY Change -86.39% -72.78% -72.78%
LONG-TERM ASSETS
Property, Plant & Equipment $4.104M $4.516M $18.13M
YoY Change -78.51% -79.22% -16.57%
Goodwill $0.00
YoY Change
Intangibles $158.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $105.0K $158.0K $158.0K
YoY Change -61.68% -13.66% -43.97%
Total Long-Term Assets $17.70M $18.29M $18.29M
YoY Change -8.62% -16.92% -16.92%
TOTAL ASSETS
Total Short-Term Assets $2.583M $4.132M $4.132M
Total Long-Term Assets $17.70M $18.29M $18.29M
Total Assets $20.29M $22.42M $22.42M
YoY Change -47.1% -39.72% -39.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $327.0K $340.0K $340.0K
YoY Change -71.98% -73.02% -73.02%
Accrued Expenses $1.052M $173.0K $280.0K
YoY Change -59.35% -48.97% -90.21%
Deferred Revenue $107.0K
YoY Change
Short-Term Debt $1.000M $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $97.00K $97.00K
YoY Change -100.0% -73.78% -73.78%
Total Short-Term Liabilities $4.200M $1.700M $1.662M
YoY Change -55.88% -64.98% -65.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $61.00K $79.00K $13.53M
YoY Change -99.56% -88.75% 1826.78%
Total Long-Term Liabilities $61.00K $79.00K $13.53M
YoY Change -99.56% -88.75% -25.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.200M $1.700M $1.662M
Total Long-Term Liabilities $61.00K $79.00K $13.53M
Total Liabilities $17.62M $15.19M $15.19M
YoY Change -24.79% -34.14% -34.14%
SHAREHOLDERS EQUITY
Retained Earnings -$217.5M -$212.2M
YoY Change 8.19%
Common Stock $221.3M $220.4M
YoY Change 4.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.667M $7.233M $7.233M
YoY Change
Total Liabilities & Shareholders Equity $20.29M $22.42M $22.42M
YoY Change -47.1% -39.72% -39.72%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$5.400M -$2.837M -$16.90M
YoY Change -3.9% -59.8% -42.12%
Depreciation, Depletion And Amortization $486.0K $376.0K $1.534M
YoY Change 31.35% -33.1% -34.39%
Cash From Operating Activities -$2.400M -$3.763M -$19.40M
YoY Change -62.52% -9.48% 3.19%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $11.00K $1.520M
YoY Change -100.0% -109.09% 205.84%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$11.00K -$1.520M
YoY Change -100.0% -90.91% -113.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.54M
YoY Change 163.42%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 903.0K 95.00K 9.989M
YoY Change -91.33% -97.49% 166.94%
NET CHANGE
Cash From Operating Activities -2.400M -3.763M -19.40M
Cash From Investing Activities 0.000 -11.00K -1.520M
Cash From Financing Activities 903.0K 95.00K 9.989M
Net Change In Cash -1.472M -3.679M -10.90M
YoY Change -142.52% 647.76% 181.67%
FREE CASH FLOW
Cash From Operating Activities -$2.400M -$3.763M -$19.40M
Capital Expenditures $0.00 $11.00K $1.520M
Free Cash Flow -$2.400M -$3.774M -$20.92M
YoY Change -59.04% -6.49% 8.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001705843
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-38161
CY2022 dei Entity Registrant Name
EntityRegistrantName
Calyxt, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
CY2022 dei City Area Code
CityAreaCode
651
CY2022 dei Local Phone Number
LocalPhoneNumber
683-2807
CY2022 dei Security12b Title
Security12bTitle
Common Stock ($(0.0001 par value)
CY2022 dei Trading Symbol
TradingSymbol
CLXT
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
5446012000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49376160
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24354000
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3427000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
99000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
606000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4132000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
15181000
CY2022Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
0
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4516000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13615000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
158000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2022Q4 us-gaap Assets
Assets
22421000
CY2021Q4 us-gaap Assets
Assets
37194000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
340000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1260000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
173000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
339000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
107000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2522000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
175000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
172000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
97000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
370000
CY2022Q4 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
291000
CY2021Q4 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
0
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
479000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1662000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4854000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17506000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13447000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702000
CY2022Q4 us-gaap Liabilities
Liabilities
15188000
CY2021Q4 us-gaap Liabilities
Liabilities
23062000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48944771
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48844619
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38874146
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38773994
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220422000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211263000
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212151000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196092000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7233000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22421000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37194000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25987000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23851000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28557000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35127000
CY2022 us-gaap Gross Profit
GrossProfit
157000
CY2021 us-gaap Gross Profit
GrossProfit
-2570000
CY2020 us-gaap Gross Profit
GrossProfit
-11276000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11553000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11335000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11082000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10974000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15427000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20789000
CY2022 us-gaap Restructuring Costs
RestructuringCosts
0
CY2021 us-gaap Restructuring Costs
RestructuringCosts
0
CY2020 us-gaap Restructuring Costs
RestructuringCosts
685000
CY2022 us-gaap Operating Expenses
OperatingExpenses
22527000
CY2021 us-gaap Operating Expenses
OperatingExpenses
26762000
CY2020 us-gaap Operating Expenses
OperatingExpenses
32556000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22370000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-29332000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-43832000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-87000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1414000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-878000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5566000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16891000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29199000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44836000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16891000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-29199000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-44836000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.32
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.32
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45997525
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45997525
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37475763
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37475763
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33882406
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33882406
CY2021 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-2542000
CY2020 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
347000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2415000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15960659
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6001405
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5552418
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62508000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-44836000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4971000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-17000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-29199000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2090000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16891000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3998000
CY2022 clxt Cumulative Effect Of Adoption Of Lease Accounting Standard
CumulativeEffectOfAdoptionOfLeaseAccountingStandard
832000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7233000
CY2022 us-gaap Profit Loss
ProfitLoss
16891000
CY2021 us-gaap Profit Loss
ProfitLoss
29199000
CY2020 us-gaap Profit Loss
ProfitLoss
44836000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1534000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2338000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1869000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3998000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2090000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
4971000
CY2022 clxt Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
UnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
-5120000
CY2021 clxt Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
UnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
0
CY2020 clxt Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
UnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
0
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4887000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3765000
CY2022 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
3000
CY2021 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-594000
CY2020 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-211000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1383000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1211000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-389000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3331000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3122000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-229000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-360000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-148000
CY2022 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-166000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
572000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-231000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
467000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-811000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-243000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19364000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18811000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43672000
CY2022 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
0
CY2021 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-11698000
CY2020 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
11698000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1520000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
497000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1786000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1520000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11201000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13484000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11538000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4380000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15000000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1173000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
501000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
963000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1518000
CY2022 clxt Repayments Of Financing Lease Obligation
RepaymentsOfFinancingLeaseObligation
376000
CY2021 clxt Repayments Of Financing Lease Obligation
RepaymentsOfFinancingLeaseObligation
364000
CY2020 clxt Repayments Of Financing Lease Obligation
RepaymentsOfFinancingLeaseObligation
360000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
212000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9989000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3742000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15407000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10895000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3868000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41749000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3526000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2022 us-gaap Year Founded
YearFounded
2010
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation and Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has prepared its consolidated financial statements in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) and has included the accounts of Calyxt and its subsidiary. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes, including those related to revenue recognition, the net realizable value of inventories, stock-based compensation, and valuation allowances on deferred tax assets. Actual results could materially differ from these estimates. </div>
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.022
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-16900000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19400000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3500000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1700000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3880000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
900000
CY2022Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
291000
CY2021 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
0.015
CY2022Q4 clxt Estimated Fair Value Of Common Warrants Measurement Input
EstimatedFairValueOfCommonWarrantsMeasurementInput
0.04
CY2021Q4 clxt Finance Lease Obligations Fair Value Disclosure
FinanceLeaseObligationsFairValueDisclosure
14500000
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-0
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2718149
CY2020 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
-0.01
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.008
CY2022 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2789110
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.23
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4658405
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.47
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1609000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.12
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
425952
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.02
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3396624
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.94
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5841453
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.35
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
212000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
179000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.042
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.005
CY2022 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
-0.014
CY2021 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0.011
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2020Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
4609000
CY2022Q4 clxt Deferred Tax Liabilities Deferred Expense Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesDeferredExpenseOperatingLeaseRightOfUseAssets
2859000
CY2021Q4 clxt Deferred Tax Liabilities Deferred Expense Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesDeferredExpenseOperatingLeaseRightOfUseAssets
0
CY2020 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0
CY2022 clxt Effective Income Tax Rate Reconciliation Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
EffectiveIncomeTaxRateReconciliationUnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
0.064
CY2021 clxt Effective Income Tax Rate Reconciliation Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
EffectiveIncomeTaxRateReconciliationUnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
0
CY2020 clxt Effective Income Tax Rate Reconciliation Unrealized Gain Loss On Mark To Market Of Common Stock Warrants
EffectiveIncomeTaxRateReconciliationUnrealizedGainLossOnMarkToMarketOfCommonStockWarrants
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.275
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.254
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.244
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
40914000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38671000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33392000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2950000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2724000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2531000
CY2022Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
0
CY2021Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
3820000
CY2020Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
4574000
CY2022Q4 clxt Deferred Tax Assets Deferred Expense Operating Lease Right Of Use Liabilities
DeferredTaxAssetsDeferredExpenseOperatingLeaseRightOfUseLiabilities
2921000
CY2021Q4 clxt Deferred Tax Assets Deferred Expense Operating Lease Right Of Use Liabilities
DeferredTaxAssetsDeferredExpenseOperatingLeaseRightOfUseLiabilities
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3685000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3210000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2577000
CY2022Q4 clxt Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
2183000
CY2021Q4 clxt Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
14000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
514000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
339000
CY2022Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0
CY2021Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0
CY2020Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
703000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
124000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
143000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
391000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52791000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49082000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44507000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49843000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45369000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39898000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2948000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
46000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2948000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3713000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4609000
CY2022Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
89000
CY2021Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
3667000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3713000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4609000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
239200000
CY2022Q4 clxt Operating Loss Carryforwards Not Expire
OperatingLossCarryforwardsNotExpire
142000000
CY2022Q4 clxt Operating Loss Carryforwards Subject To Expire
OperatingLossCarryforwardsSubjectToExpire
41900000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
750000
CY2022Q4 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P20Y
CY2022Q4 clxt Number Of Lease Extension Options
NumberOfLeaseExtensionOptions
4
CY2022Q4 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
7000000
CY2022 clxt Sale Leaseback Transaction Base Rent Interest Rate
SaleLeasebackTransactionBaseRentInterestRate
0.08
CY2022Q4 clxt Sale Leaseback Transaction Incremental Rent Percentage Annual
SaleLeasebackTransactionIncrementalRentPercentageAnnual
0.075
CY2022 clxt Sale Leaseback Transaction Annual Base Rent Payments
SaleLeasebackTransactionAnnualBaseRentPayments
1400000
CY2022 clxt Finance Lease Cost
FinanceLeaseCost
75000
CY2021 clxt Finance Lease Cost
FinanceLeaseCost
1431000
CY2020 clxt Finance Lease Cost
FinanceLeaseCost
1435000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1548000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
46000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
83000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
942000
CY2022 us-gaap Lease Cost
LeaseCost
2565000
CY2021 us-gaap Lease Cost
LeaseCost
1477000
CY2020 us-gaap Lease Cost
LeaseCost
1518000
CY2022 clxt Payment Of Operating Lease Included In Operating Cash Flow
PaymentOfOperatingLeaseIncludedInOperatingCashFlow
276000
CY2022 clxt Payment Of Finance Lease Included In Operating Cash Flow
PaymentOfFinanceLeaseIncludedInOperatingCashFlow
0
CY2022 clxt Payment Of Operating Lease Included In Financing Cash Flow
PaymentOfOperatingLeaseIncludedInFinancingCashFlow
0
CY2022 clxt Payment Of Finance Lease Included In Financing Cash Flow
PaymentOfFinanceLeaseIncludedInFinancingCashFlow
376000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y3M18D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1446000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
100000
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments Next Twelve Months
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwelveMonths
1546000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1480000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments Next Two Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwoYears
1480000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1479000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments Next Three Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextThreeYears
1479000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1479000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments Next Four Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFourYears
1479000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1479000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments Next Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFiveYears
1479000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16991000
CY2022Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2022Q4 clxt Operating And Finance Lease Liabilities Payments After Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsAfterFiveYears
16991000
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
100000
CY2022Q4 clxt Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
24454000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10540000
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
3000
CY2022Q4 clxt Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
10543000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13814000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
97000
CY2022Q4 clxt Lessee Operating And Finance Lease Liability
LesseeOperatingAndFinanceLeaseLiability
13911000
CY2022 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company provides a 401(k) defined contribution plan for all regular full-time employees who have completed two months of service.
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
259000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
274000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
309000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3427000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
99000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
0
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3526000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
14421000
CY2022 clxt Common Warrants Financing Cost
CommonWarrantsFinancingCost
396000
CY2021 clxt Common Warrants Financing Cost
CommonWarrantsFinancingCost
0
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
210000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
859000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
606000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
367000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022 clxt Other Current Liabilities
OtherCurrentLiabilities
112000
CY2021 clxt Other Current Liabilities
OtherCurrentLiabilities
191000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
479000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10393000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29459000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5877000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7728000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4516000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25987000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23851000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3998000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2090000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4971000
CY2022 us-gaap Interest Expense
InterestExpense
75000
CY2021 us-gaap Interest Expense
InterestExpense
1431000
CY2020 us-gaap Interest Expense
InterestExpense
1435000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
60000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
17000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
557000
CY2022 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
72000
CY2021 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
CY2020 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-87000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1414000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-878000
CY2022 us-gaap Interest Paid
InterestPaid
69000
CY2021 us-gaap Interest Paid
InterestPaid
1425000
CY2020 us-gaap Interest Paid
InterestPaid
1455000
CY2022 clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
-260000
CY2021 clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
260000
CY2020 clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
0
CY2022 clxt Noncash Or Part Noncash Acquisition Fixed Assets Acquired
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired
-691000
CY2021 clxt Noncash Or Part Noncash Acquisition Fixed Assets Acquired
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired
691000
CY2020 clxt Noncash Or Part Noncash Acquisition Fixed Assets Acquired
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired
0
CY2022 clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
832000
CY2021 clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
0
CY2020 clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
0
CY2022 clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
14090000
CY2021 clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
0
CY2020 clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
0

Files In Submission

Name View Source Status
0001193125-23-058346-index-headers.html Edgar Link pending
0001193125-23-058346-index.html Edgar Link pending
0001193125-23-058346.txt Edgar Link pending
0001193125-23-058346-xbrl.zip Edgar Link pending
clxt-20221231.xsd Edgar Link pending
d425657d10k.htm Edgar Link pending
d425657dex1044.htm Edgar Link pending
d425657dex231.htm Edgar Link pending
d425657dex311.htm Edgar Link pending
d425657dex312.htm Edgar Link pending
d425657dex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g425657g58x99.jpg Edgar Link pending
g425657g65t55.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
clxt-20221231_def.xml Edgar Link unprocessable
clxt-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d425657d10k_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clxt-20221231_lab.xml Edgar Link unprocessable
clxt-20221231_cal.xml Edgar Link unprocessable